Skip to main content
v2026.11,986 entries · CC-BY 4.0

Telehealth Informed Consent: Regulatory Elements, Digital Intake, and AI Disclosures

A clinical risk and health informatics guide to telehealth informed consent, detailing AHRQ and FSMB mandatory disclosure elements, state Medicaid and medical board rules, integration into automated digital patient intake workflows, HL7 FHIR Consent mapping, and AI scribe disclosure clauses.

Written and maintained by CASRAI Editorial Board

Published

On this page

Telehealth informed consent (also termed informed consent telemedicine) is the clinical and legal process of educating a patient about the specific operational scope, diagnostic limitations, electronic privacy risks, emergency escalation protocols, and financial responsibilities of receiving healthcare via synchronous audio-video, audio-only, or asynchronous store-and-forward technology, and documenting the patient’s voluntary agreement prior to initiating virtual care.

Unlike a general HIPAA Notice of Privacy Practices acknowledgement (see HIPAA authorization vs informed consent), telehealth informed consent is governed by state medical practice acts, state Medicaid agency reimbursement rules, and clinical practice standards issued by the Agency for Healthcare Research and Quality (AHRQ) and the Federation of State Medical Boards (FSMB).

To understand what is telehealth informed consent from a clinical risk management perspective, organizations must distinguish between standard medical treatment consent and the modality-specific risks introduced by remote care. According to AHRQ’s guidance on obtaining informed consent for telehealth and FSMB’s telemedicine policy framework, a legally and clinically defensible telehealth consent instrument must disclose seven core elements:

  1. Nature and Modality of the Telemedicine Encounter: A plain-language explanation of whether the service uses real-time interactive audio-video, audio-only telephone, asynchronous store-and-forward image/data transmission, or remote patient monitoring (RPM).
  2. Diagnostic Limitations of Virtual Examination: An explicit disclosure that the clinician cannot perform hands-on physical palpation, auscultation (unless peripheral hardware is present), or immediate point-of-care testing, and that technical failures or clinical ambiguity may require converting the encounter to an in-person office or emergency department visit.
  3. Originating Site Location & Emergency Escalation Protocol: Confirmation that the patient must disclose their exact physical address and telephone number at the start of every virtual visit (see originating site telehealth) so the clinician can dispatch local emergency medical services (EMS) if a medical or behavioral health crisis occurs and verify state licensure jurisdiction.
  4. Electronic Security and Privacy Risks: Disclosure that although the telehealth platform uses HIPAA-compliant encryption (such as WebRTC DTLS-SRTP), electronic transmissions carry residual cybersecurity risks, and patients are responsible for ensuring privacy in their physical environment.
  5. Third-Party Observers, Trainees, and Family Members: Rules requiring both the clinician and the patient to disclose all individuals present in the room at the distant and originating sites, and requiring patient permission before medical students, residents, or interpreters join the virtual session.
  6. Right to Withdraw or Refuse Telehealth: Assurance that the patient may withhold or withdraw consent to telehealth at any time without losing the right to future care or treatment.
  7. Billing, Co-Payments, and Out-of-Network Disclosures: Explanation of insurance coverage, patient cost-sharing, and applicable self-pay rates before the session begins.
Consent Modality Primary Clinical Use Case Verification & Audit Trail Mechanism Regulatory & Payer Considerations
Pre-Visit Electronic Signature (eConsent) Scheduled ambulatory video visits and longitudinal specialty clinics Timestamped electronic signature, IP address, and PDF/FHIR `Consent` archive during digital intake Satisfies all state written and verbal consent statutes; preferred for audit readiness
Documented Verbal Consent at Visit Start Urgent care telemedicine, audio-only visits, or patients unable to complete pre-visit forms Clinician reads standardized script on call and selects structured EHR smart-phrase attestation Permitted by most state medical boards and Medicare CCM/RPM rules when documented in the chart
Multi-Part AI & Recording Consent Telehealth visits utilizing ambient AI medical scribes or session video recording Explicit opt-in checkbox or recorded verbal consent covering voice capture and AI processing Required under two-party (all-party) state wiretapping laws and institutional AI governance

Examining how is telehealth informed consent used in clinical research and healthcare highlights how modern health systems embed consent directly into automated pre-visit workflows and decentralized clinical trials:

1. Integration into Automated Patient Intake and Telemedicine Workflows

In high-volume ambulatory clinics, collecting verbal consent during the first three minutes of every 15-minute video appointment erodes clinician time. Consequently, health systems embed telehealth informed consent directly into the pre-visit digital patient intake and patient intake process:

  • Automated Pre-Visit Triggering: When an appointment is booked with a telehealth place-of-service code (POS 02 or POS 10), the automated patient intake engine checks whether the patient has an active, non-expired telehealth consent on file (typically valid for 12 months under institutional policy, unless state law requires per-encounter attestation).
  • Telehealth Workflow Gating: Before entering the virtual waiting room, the patient completes identity verification, confirms their current physical state/address for licensure routing, signs the electronic telehealth consent form, and completes clinical screening questionnaires on their smartphone or browser.

A rapidly expanding regulatory requirement is informed consent artificial intelligence within the telehealth workflow and telemedicine workflow. When clinicians deploy ambient AI medical scribes, real-time transcription, or generative clinical decision support during a virtual visit, general telehealth consent is frequently insufficient on its own:

  • All-Party Wiretapping & Biometric Laws: In all-party (two-party) recording consent jurisdictions (such as California, Florida, Illinois, Massachusetts, Pennsylvania, and Washington), recording or streaming patient-clinician conversation to a third-party cloud speech processor without explicit consent violates state wiretapping statutes. Organizations therefore pair general telehealth consent with a dedicated AI scribe consent form clause disclosing that an AI tool is transcribing the visit to draft clinical notes and that a licensed clinician reviews and edits the final record.
  • State AI Healthcare Disclosure Mandates: Recent state legislation (such as California AB 3030 and Texas / Utah AI disclosure frameworks) establishes transparency requirements when generative AI is used to communicate clinical information to patients, reinforcing the practice of including explicit AI disclosure language in patient intake packets.

In health informatics and decentralized clinical trials (governed by FDA Electronic Informed Consent guidance under 21 CFR Parts 11 and 50 and ICH E6(R3) Annex 2), telehealth consent is stored and exchanged using the HL7 FHIR R4 `Consent` resource:

  • `Consent.scope` & `Consent.category`: Coded to distinguish clinical treatment teleconsent (`treatment`), research participation (`research`), and privacy disclosures (`patient-privacy`).
  • `Consent.sourceAttachment` / `Consent.sourceReference`: Links the structured FHIR resource to the signed PDF artifact (`DocumentReference`) or completed `QuestionnaireResponse` captured during digital patient intake.
  • `Consent.provision`: Encodes granular opt-in/opt-out permissions (such as permitting telehealth treatment while declining session recording or secondary AI model training).

Frequently Asked Questions

Telehealth informed consent is the process of informing a patient about how telemedicine works, the diagnostic limitations of a remote exam compared to an in-person visit, electronic privacy and security risks, emergency location protocols, and billing policies, and recording the patient’s agreement before delivering virtual care.

In healthcare, telehealth informed consent is integrated into automated digital patient intake workflows—or documented verbally at the start of a virtual visit—to satisfy state medical board, Medicaid, and malpractice risk requirements, as well as to obtain permission for ambient AI medical scribes. In clinical research, electronic informed consent (eConsent) conducted via telehealth allows investigators to enroll and consent remote trial participants under FDA 21 CFR Part 11/50 and ICH E6(R3) decentralized trial guidelines.

Sources

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · free to try

Ask about Telehealth Informed Consent: Regulatory Elements, Digital Intake, and AI Disclosures

Ask your first 2 questions free below. Subscribers get 150 a day for $29 a month.

An AI assistant specialized in research administration. It cites the sources behind every answer, labels web answers and says when it can't answer.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →